Skip to main content
Lotus Pharm logo

Lotus Pharm — Investor Relations & Filings

Ticker · 1795 ISIN · TW0001795003 LEI · 984500BEECDBC04KP716 TW Manufacturing
Open in API
Filings indexed 2,730 across all filing types
Latest filing 2024-03-14 Regulatory Filings
Country TW Taiwan
Listing TW 1795

About Lotus Pharm

http://www.lotuspharm.com.tw

Lotus Pharmaceutical Co., Ltd. is a global specialty organization focused on the development, manufacturing, and commercialization of high-barrier generic and specialty medicines. The company specializes in complex generics, with a primary focus on oncology, immunology, and addiction treatment. Its portfolio includes technically demanding products such as Lenalidomide, Suboxone, Nintedanib, and Vinorelbine, as well as an advancing pipeline of biosimilars and 505(b)(2) oncology candidates. Utilizing an integrated R&D and manufacturing platform, the company executes a "2x2" growth strategy centered on dual market expansion and product diversification. Its commercial footprint spans over 90 markets globally, maintaining a strong presence in the Asia-Pacific region and the United States. The company prioritizes high technical entry barriers and cost-effective therapeutic solutions to improve global patient access to essential medications.

Recent filings

Filing Released Lang Actions
112年度應收帳款周轉率
Regulatory Filings Classification · 90% confidence The document is very short (282 characters) and contains a brief table with financial ratios (accounts receivable turnover and average collection days) for two fiscal years (111 and 112). There is no detailed financial statement, management discussion, or comprehensive report content. It appears to be a small excerpt or a brief financial metric disclosure rather than a full report. Given the brevity and nature of the content, it does not qualify as an Annual Report, Interim Report, or Earnings Release. It also does not fit into categories like Board/Management changes, Legal Proceedings, or Capital Updates. Since it is a short disclosure of financial metrics without detailed analysis or full financial data, the best fit is Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2024-03-14 Chinese
112年度存貨週轉率
Fund Information / Factsheet Classification · 85% confidence The document is very short (279 characters) and contains inventory turnover ratios and average sales days for two fiscal years (111 and 112). It appears to be a brief financial metric disclosure without detailed financial statements or analysis. There is no indication of a full report, announcement of a report, or regulatory filing. Given the nature of the data (inventory turnover and sales days) and the brevity, it fits best as a brief fact sheet or summary of key financial metrics. Therefore, the most appropriate classification is Fund Information / Factsheet (FS).
2024-03-14 Chinese
112年度毛利率
Fund Information / Factsheet Classification · 90% confidence The document contains annual financial data for two consecutive years, including net operating revenue, operating costs, gross profit, and gross margin percentages. The data is summarized in a tabular format and includes a note about significant changes in gross margin. The document length is very short (392 characters), and it appears to be a brief financial summary rather than a full annual report or detailed financial statement. There is no indication that this is an announcement of a report publication or a certification. Given the brevity and nature of the content, it best fits the category of a Fund Information / Factsheet (FS), which typically provides brief summaries of key financial facts.
2024-03-14 Chinese
112年度營益分析
Interim / Quarterly Report Classification · 95% confidence The document contains detailed quarterly and annual financial data including revenue, gross margin, operating profit margin, pre-tax profit margin, and after-tax profit margin for multiple fiscal years. The data is structured by fiscal periods such as first quarter, half-year, third quarter, and full year. The presence of substantive financial data and analysis for periods shorter than a full fiscal year indicates this is a comprehensive interim or quarterly financial report rather than a brief announcement or summary. The document length is relatively short (1067 characters), but it contains actual financial figures and ratios, which excludes it from being a mere report publication announcement or regulatory filing. Therefore, the document best fits the definition of an Interim / Quarterly Report (IR). FY 2023
2024-03-14 Chinese
112年第4季權益變動表
Interim / Quarterly Report Classification · 85% confidence The document contains detailed tables of consolidated equity changes, including items such as common stock, capital surplus, legal surplus reserves, undistributed earnings, and other equity components for the current and previous fiscal periods. The data is presented in a structured financial format with monetary units and period comparisons. The content is typical of a financial statement or report section showing changes in equity, which is a component of comprehensive financial reporting. The document length is 4460 characters, which is relatively short but contains substantive financial data rather than just an announcement or certification. There is no indication that this is a mere announcement or a certification letter. The document does not appear to be a full annual report but rather a specific financial statement or part of an interim/quarterly report. Given the detailed financial data and the nature of the content, the best fitting category is Interim / Quarterly Report (IR). FY 2023
2024-03-14 Chinese
112年第4季現金流量表
Interim / Quarterly Report Classification · 95% confidence The document contains a detailed consolidated cash flow statement for the fiscal year 112 (2023) Q4 and the previous year 111 (2022). It includes comprehensive financial data such as net profit before tax, depreciation, amortization, changes in assets and liabilities, cash flows from operating, investing, and financing activities, and ending cash balances. The presence of actual financial statements and substantive financial data for a quarterly period indicates this is a financial report rather than an announcement or certification. The document length is 3064 characters, which is relatively short but contains detailed financial data, so it is not merely an announcement. The content matches the characteristics of an Interim / Quarterly Report (IR). FY 2023
2024-03-14 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.